JP2017514867A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017514867A5 JP2017514867A5 JP2016566786A JP2016566786A JP2017514867A5 JP 2017514867 A5 JP2017514867 A5 JP 2017514867A5 JP 2016566786 A JP2016566786 A JP 2016566786A JP 2016566786 A JP2016566786 A JP 2016566786A JP 2017514867 A5 JP2017514867 A5 JP 2017514867A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- alkyl
- optionally substituted
- heterocyclyl
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *C1COCC1 Chemical compound *C1COCC1 0.000 description 2
- JTRNQTFTRDPITG-UHFFFAOYSA-N IC1CCOCC1 Chemical compound IC1CCOCC1 JTRNQTFTRDPITG-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14167373 | 2014-05-07 | ||
| EP14167373.1 | 2014-05-07 | ||
| PCT/EP2015/059453 WO2015169677A1 (en) | 2014-05-07 | 2015-04-30 | Sulfoximine substituted quinazolines for pharmaceutical compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017514867A JP2017514867A (ja) | 2017-06-08 |
| JP2017514867A5 true JP2017514867A5 (show.php) | 2018-09-20 |
| JP6479854B2 JP6479854B2 (ja) | 2019-03-06 |
Family
ID=50639371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016566786A Expired - Fee Related JP6479854B2 (ja) | 2014-05-07 | 2015-04-30 | 医薬組成物のためのスルホキシイミン置換キナゾリン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10167296B2 (show.php) |
| EP (1) | EP3140300B1 (show.php) |
| JP (1) | JP6479854B2 (show.php) |
| AU (1) | AU2015257917C1 (show.php) |
| CA (1) | CA2944103A1 (show.php) |
| ES (1) | ES2749186T3 (show.php) |
| WO (1) | WO2015169677A1 (show.php) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20170066778A1 (en) * | 2015-09-04 | 2017-03-09 | Aunova Medchem LLC | Solubility for target compounds |
| WO2017165908A1 (en) * | 2016-03-31 | 2017-10-05 | South Australian Health And Medical Research Institute Limited | Method of inhibiting high fat diet-related conditions |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19712960A1 (de) | 1997-03-27 | 1998-10-01 | Hoechst Ag | Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten |
| SE0102147D0 (sv) | 2001-06-18 | 2001-06-18 | Pharmacia Ab | New methods |
| ATE494912T1 (de) | 2001-10-29 | 2011-01-15 | Boehringer Ingelheim Int | Mnk-kinase-homologe proteine, die an der regulierung der energiehomöostase und dem organellen metabolismus beteiligt sind |
| GB0315587D0 (en) | 2003-07-03 | 2003-08-13 | Univ Dundee | Anti-inflammatory assay and compounds |
| KR101151932B1 (ko) | 2004-04-08 | 2012-06-01 | 다우 아그로사이언시즈 엘엘씨 | 살충성 ｎ-치환된 설폭시민 |
| EP1746099A1 (en) | 2004-12-23 | 2007-01-24 | DeveloGen Aktiengesellschaft | Mnk1 or Mnk2 inhibitors |
| JP5301986B2 (ja) * | 2005-06-22 | 2013-09-25 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 医薬組成物用のチエノピリミジン類 |
| ZA200807715B (en) | 2006-03-09 | 2009-11-25 | Pharmacopeia Inc | 9-Heteroarylpurine MNK2 inhibitors for treating metabolic disorders |
| CA2651898A1 (en) * | 2006-04-07 | 2007-10-18 | Develogen Aktiengesellschaft | Thienopyrimidines having mnk1/mnk2 inhibiting activity for pharmaceutical compositions |
| CN101472912A (zh) | 2006-06-22 | 2009-07-01 | 比奥维特罗姆上市公司 | 作为mnk激酶抑制剂的吡啶和吡嗪衍生物 |
| EP1889847A1 (en) * | 2006-07-10 | 2008-02-20 | DeveloGen Aktiengesellschaft | Pyrrolopyrimidines for pharmaceutical compositions |
| CA2687611A1 (en) * | 2007-05-24 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Novel sulphoximine-substituted quinoline and quinazoline derivatives as kinase inhibitors |
| CN102186857A (zh) * | 2008-08-26 | 2011-09-14 | 贝林格尔·英格海姆国际有限公司 | 用于药物组合物的噻吩并嘧啶 |
| WO2010117425A1 (en) | 2009-03-31 | 2010-10-14 | Biogen Idec Ma Inc. | Certain substituted pyrimidines, pharmaceutical compositions thereof, and methods for their use |
| TW201111378A (en) | 2009-09-11 | 2011-04-01 | Bayer Schering Pharma Ag | Substituted (heteroarylmethyl) thiohydantoins |
| UY33241A (es) * | 2010-02-26 | 2011-09-30 | Boehringer Ingelheim Int | ?Tienopirimidinas que contienen heterocicloalquilo para composiciones farmacéuticas?. |
| WO2011104334A1 (en) * | 2010-02-26 | 2011-09-01 | Boehringer Ingelheim International Gmbh | 4 - [cycloalkyloxy (hetero) arylamino] thieno [2, 3 - d] pyrimidines having mnkl/ mnk2 inhibiting activity for pharmaceutical compositions |
| BR112012021453A2 (pt) * | 2010-02-26 | 2017-02-21 | Boehringer Ingelheim Int | tienopirimidina, sua composição farmacêutica e seu uso |
| US9170933B2 (en) * | 2010-06-28 | 2015-10-27 | International Business Machines Corporation | Wear-level of cells/pages/sub-pages/blocks of a memory |
| AR088082A1 (es) | 2011-10-13 | 2014-05-07 | Lilly Co Eli | Moduladores selectivos del receptor androgeno |
| JP6234444B2 (ja) | 2012-05-21 | 2017-11-22 | バイエル ファーマ アクチエンゲゼルシャフト | チエノピリミジン類 |
| TW201412740A (zh) * | 2012-09-20 | 2014-04-01 | Bayer Pharma AG | 經取代之吡咯并嘧啶胺基苯并噻唑酮 |
| JP2015535833A (ja) * | 2012-09-26 | 2015-12-17 | バイエル・ファルマ・アクティエンゲゼルシャフト | 過剰増殖疾患の治療において有用な置換インダゾール−ピロロピリミジン |
| ES2635262T3 (es) | 2012-11-09 | 2017-10-03 | Evotec International Gmbh | Quinazolinas sustituidas con sulfoximina para composiciones farmacéuticas |
| CN105377845B (zh) * | 2013-02-01 | 2017-11-24 | 拜耳制药股份公司 | 取代的吡唑并嘧啶基氨基‑吲唑类 |
| CA2914525C (en) | 2013-06-28 | 2021-07-27 | Evotec International Gmbh | Sulfoximine substituted quinazolines for pharmaceutical compositions |
| ES2693520T3 (es) * | 2013-12-04 | 2018-12-12 | Evotec International Gmbh | Quinazolinas sustituidas con sulfoximina para composiciones farmacéuticas |
-
2015
- 2015-04-30 EP EP15720077.5A patent/EP3140300B1/en active Active
- 2015-04-30 ES ES15720077T patent/ES2749186T3/es active Active
- 2015-04-30 WO PCT/EP2015/059453 patent/WO2015169677A1/en not_active Ceased
- 2015-04-30 US US15/308,712 patent/US10167296B2/en active Active
- 2015-04-30 CA CA2944103A patent/CA2944103A1/en active Pending
- 2015-04-30 JP JP2016566786A patent/JP6479854B2/ja not_active Expired - Fee Related
- 2015-04-30 AU AU2015257917A patent/AU2015257917C1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3036123T3 (en) | Heterocyclic rip1 kinase inhibitors | |
| CA2903288C (en) | N-acyl-n'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities | |
| JP7145931B2 (ja) | 化合物の結晶多形、その製造方法及び用途 | |
| CA3142069A1 (en) | Aurora kinase inhibitor and use thereof | |
| CN108727378A (zh) | 新型异喹啉类化合物及其医药用途 | |
| JP2016121196A5 (show.php) | ||
| JP2018515495A5 (show.php) | ||
| JP2016512823A5 (show.php) | ||
| AU2014234906B2 (en) | Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors | |
| CN105934432A (zh) | 2,4-二取代苯-1,5-二胺衍生物及其应用以及由其制备的药物组合物和药用组合物 | |
| MX2015004787A (es) | Compuestos antiviricos para el virus sincitial respiratorio. | |
| JP2016519165A5 (show.php) | ||
| AU2015335783B2 (en) | Tricyclic atropisomer compounds | |
| JP2015508092A5 (show.php) | ||
| CN110776481B (zh) | 一类双阳离子化合物及其制备方法和用途 | |
| JP2017527598A5 (show.php) | ||
| WO2017084640A1 (zh) | 一种含氮杂环化合物及其制备方法与在抑制激酶活性中的应用 | |
| JP2019532067A5 (show.php) | ||
| JP2015502371A5 (show.php) | ||
| EP3373931A1 (en) | Heterocyclic compounds for the treatment of disease | |
| US20190202826A1 (en) | Phosphotidylinositol 3-Kinase Inhibitors | |
| WO2018133875A1 (zh) | Jak酶抑制剂及其制备方法和用途 | |
| JP2025540714A (ja) | Ｌｐａ受容体活性と関連する状態を処置するための化合物および組成物 | |
| JP2017514867A5 (show.php) | ||
| JP2020517676A5 (show.php) |